Mölnlycke and Ondine join forces against HAIs
Mölnlycke Health Care partners with Ondine for Steriwave distribution collaboration in the key markets of the UK, Europe and the Middle East.Gothenburg, Sweden 23 September 2024. Mölnlycke® Health Care, a world-leading MedTech company that specialises in innovative solutions for wound care and surgical procedures and Ondine Biomedical Inc. (LON: OBI), a Canadian life sciences company pioneering light-activated antimicrobial treatments, are pleased to announce a strategic partnership to bring Ondine’s Steriwave® nasal decolonisation technology to the United Kingdom, EU and Middle East